Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -1,341 | -7,058 | -5,709 | -3,898 |
| Other Working Capital | 116 | 147 | -78 | -424 |
| Other Operating Activity | 149 | 1,306 | 1,157 | 1,007 |
| Operating Cash Flow | $-1,075 | $-5,605 | $-4,629 | $-3,314 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 87 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 2,619 | 1,719 |
| Other Financing Activity | 639 | 3,146 | -612 | -388 |
| Financing Cash Flow | $726 | $3,146 | $2,007 | $1,331 |
| Beginning Cash Position | 351 | 2,810 | 2,810 | 2,810 |
| End Cash Position | 1 | 351 | 187 | 826 |
| Net Cash Flow | $-350 | $-2,459 | $-2,622 | $-1,984 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,075 | -5,605 | -4,629 | -3,314 |
| Free Cash Flow | -1,075 | -5,605 | -4,629 | -3,314 |